C
Climb Bio, Inc.
CLYM · NASDAQ · Healthcare · 935M
Closing price
$11.00
+1.29% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.6×
Enterprise value / EBITDAEV/EBITDA
-11.9×
Free cash flow yieldFCF yield
-7.3%
Return on equityROE
-37.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.